We examined the hypothesis that substance P (SP) and the neurokinin-1 receptor (NK-1R), both in vitro and in vivo, promote mucosal healing during recovery from colitis by stimulating antiapoptotic pathways in human colonic epithelial cells. For the in vitro experiments, human nontransformed NCM460 colonocytes stably transfected with NK-1R (NCM460-NK-1R cells) were exposed to SP, and cell viability assays, TUNEL assays, and Western blot analyses were used to detect apoptotic and antiapoptotic pathways. SP exposure of NCM460-NK-1R colonocytes stimulated phosphorylation of the antiapoptotic molecule Akt and inhibited tamoxifeninduced cell death and apoptosis evaluated by the cell viability assay and poly(ADP-ribose) polymerase cleavage, respectively. SP-induced phosphorylation of Akt and cleavage of poly(ADPribose) polymerase were inhibited by blockade of integrin ␣V␤3, Jak2, and activation of phosphatidylinositol 3-kinase. For the in vivo experiments, C57BL/6 mice, administered 5% dextran sulfate (DSS) dissolved in tap water for 5 days followed by a 5-day recovery period, were treated with the NK-1R antagonist CJ-12,255 or vehicle. Vehicle-treated mice showed increased colonic Akt phosphorylation and apoptosis compared with mice that received no DSS. In contrast, daily i.p. administration of CJ-12,255 for 5 days post-DSS suppressed Akt activation, exacerbated colitis, and enhanced apoptosis, and pharmacologic inhibition of Akt, either alone or together with CJ-12,255, produced a similar effect. Thus, SP, through NK-1R, possesses antiapoptotic effects in the colonic mucosa by activating Akt, which prevents apoptosis and mediates tissue recovery during colitis.
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apoptosis ͉ colitis S ubstance P (SP), an 11-aa neuropeptide member of the tachykinin family isolated by Chang and Leeman (1) , is broadly distributed in the central nervous system (2) . In the gastrointestinal tract, SP and its neurokinin-1 receptor (NK-1R) are expressed on several intestinal cell types, including colonocytes (3) (4) (5) , and mediate multiple functions, such as motility (6) , mucosal permeability (7), chloride secretion (8) , and colonic epithelial cell proliferation (9) . Studies indicate a major proinflammatory role for SP and the NK-1R in intestinal inflammation of different etiologies (7, (10) (11) (12) . Pharmacological antagonism of NK-1R (7, 11, 12) or genetic deletion of this receptor results in reduced intestinal inflammation in the acute model of colitis induced by Clostridium difficile toxin A (13) . Interestingly, studies with NK-1R-deficient mice showed that this receptor plays a protective role in prolonged experimental colitis induced by 2,4,6-trinitrobenzensulfonic acid and dextran sulfate (DSS) (14) . The mechanisms involved in this protective effect are activation of epidermal growth factor receptor (EGFR)-dependent mitogen-activated protein kinase (MAPK) phosphorylation, and cell proliferation of colonic fibroblasts (15) and colonic epithelial cells (9) .
Apoptosis is programmed cell death that contributes to tissue damage (16) and might affect colonic inflammatory responses. For example, reduced apoptotic responses in colonic epithelial CaCo-2 cells improve viability and transmembrane resistance (17) . Apoptosis is also evident in the colonic mucosa of patients with inflammatory bowel disease (IBD) (18) , and in the DSS model of colitis (19) . Akt, or protein kinase B, plays a critical role in controlling the balance of survival and apoptosis (20, 21) . Akt promotes cell survival and inhibits apoptosis by phosphorylating and inactivating Bad (22) , forkhead transcriptional factors (23) , and caspase 9 (24) . Akt activation also protects cells against apoptosisinducing agents such as Fas ligand (FasL) (25) . Previous results indicate that SP exerts antiapoptotic responses in rat kidney epithelial cells by a ␤-arrestin-and ERK1/2-dependent mechanism (26) . However, the possibility that SP exerts antiapoptotic responses by Akt activation in colonocytes has never been investigated, and the importance of this response in the pathophysiology of colonic inflammation has not been examined.
Based on the evidence indicating that the NK-1R might play an important role in mucosa recovery during colitis, we hypothesized that SP mediates antiapoptotic responses, thus reducing tissue damage during colitis by means of a mechanism that involves Akt phosphorylation. To address this hypothesis we used normal nontransformed colonic epithelial NK-1R-over-expressing NCM460-NK-1R cells and studied the antiapoptotic mechanisms of SP-NK-1R interaction. We also used the mouse DSS model of colitis to determine the possible role of SP-NK-1R interactions in mucosal apoptosis during the recovery phase of colitis in vivo by using a specific NK-1R antagonist. The importance of Akt, as well as Akt-NK-1R interactions, in this model was also evaluated. We report that SP by means of NK-1R triggers Akt phosphorylation that inhibits apoptosis in colonic epithelial cells, and that this response is correlated with improved healing and recovery from DSS-induced colitis.
Results
In Vitro Experiments. SP induces time-and dose-dependent Akt phosphorylation in human colonocytes. SP (10 nM) induced a timedependent Akt phosphorylation at Ser-473 starting at 10 min and evident throughout the 60-min incubation period (Fig. 1A) . This effect was also dose-dependent at SP concentrations ranging from 10 to 100 nM, whereas concentrations of 0.1 and 1 nM had no effect (Fig. 1B) .
SP-induced Akt phosphorylation is mediated by NK-1R and involves Janus kinase 2 (Jak2) and PI3K activation. We previously showed that SP-NK-1R interactions lead to Jak2 phosphorylation (27) . Previous results also indicate that the signaling molecule PI3K is upstream of Akt signaling (28) . To explore the possible upstream pathways of Akt phosphorylation in response to SP, we pretreated NCM460-NK-1R colonocytes with the Jak2 inhibitor AG490 (50 M) or the PI3K inhibitor LY294002 (20 M) 30 min before SP exposure. We found that both inhibitors significantly reduced SP-induced Akt phosphorylation (Fig. 1C) , indicating that Jak2 and PI3K are involved in SP-mediated Akt activation. As expected, the Akt inhibitor V (40 M) also blocked SP-induced Akt phosphorylation, whereas the MEK antagonist PD98059 (25 M) did not affect SP-induced Akt phosphorylation (Fig. 1C) . Exposure of colonocytes to CJ-12,255 blocked SP-induced Akt phosphorylation [see supporting information (SI) Fig. 8 ].
SP rescues colonic epithelial cells from tamoxifen-induced apoptosis and cell death. Tamoxifen exerts oxidative stress on mitochondria (29) , leading to cytochrome c release that mediates poly(ADP-ribose) polymerase (PARP) cleavage and activation, and subsequent DNA fragmentation and cell death (30) . We next exposed NCM460-NK-1R colonocytes to tamoxifen (10 M) for 24 h with or without SP, and cell viability was measured by an assay with the tetrazolium compound MTS as described in Materials and Methods. SP at 10 nM inhibited tamoxifen-induced cell death (indicated by absorbance reading at 490 nm) ( Fig. 2A) . In the absence of tamoxifen, 10 nM SP stimulated cell proliferation (Fig. 2 A) , confirming our prior observations (9) .
Because the MTS assay cannot distinguish cell death caused by necrosis or apoptosis, we examined the effect of SP on tamoxifenmediated PARP cleavage, an established apoptotic response. Incubation with tamoxifen caused temporary expression of cleaved PARP between 4 and 8 h, and SP reversed this effect (Fig. 2B ). As shown in Fig. 2C , this SP effect was also dose-dependent at concentrations ranging between 0.1 and 100 nM (Fig. 2C ). These results indicate that SP mediates antiapoptotic effects in colonocytes by reducing tamoxifen-induced apoptosis and PARP cleavage.
SP rescues colonocytes from tamoxifen-induced DNA fragmentation by an
Akt-dependent mechanism. To confirm the antiapoptotic effects of SP in colonocytes, we treated NCM460-NK-1R cells with tamoxifen for 24 h in the presence or absence of SP and examined DNA fragmentation by the TUNEL assay (Fig. 3) . Under control conditions, few apoptotic cells were detected (Fig. 3A) , whereas tamoxifen exposure increased the number of TUNEL-positive cells (Fig. 3B ). In the presence of SP, tamoxifen-induced TUNELpositive cells were significantly reduced (Fig. 3C) . Pretreatment with the Akt inhibitor V reversed this SP effect (Fig. 3E) , indicating that the antiapoptotic effects of SP were Akt-dependent. As expected, coadministration of tamoxifen with the Akt inhibitor V did not alter tamoxifen-induced apoptosis because tamoxifen induces cell apoptosis without activation of Akt (Fig. 3D) .
Because, as shown in Fig. 1 , Jak2 and PI3K mediated SP-induced Akt phosphorylation in colonocytes, we next used pharmacological approaches to determine participation of these signaling molecules in SP-associated antiapoptotic responses after tamoxifen-induced cell death. Inhibition of PI3K, Akt, and Jak significantly diminished SP-mediated rescue from tamoxifen-induced cell death (Fig. 4A) . On the other hand, in the absence of SP, cell viability was not further affected by any of these inhibitors (Fig. 4A) .
To further illustrate the antiapoptotic mechanisms of SP, we exposed cells to the PI3K inhibitor LY294002 and the Akt inhibitor V in the presence or absence of SP. As shown in Fig. 4B , tamoxifencaused PARP cleavage was not affected by the PI3K or the Akt inhibitors but was dramatically reduced by addition of SP (Fig. 4B) . However, inhibition of PI3K or Akt disrupted SP-mediated reduction of PARP cleavage (Fig. 4B ). This evidence indicates that SP-mediated antiapoptotic responses involve PI3K-mediated Akt activation. Integrin ␣V␤3 is involved in SP-induced Jak2-Akt signaling. Integrin is a receptor that binds to extracellular matrix proteins such as vitronectin (31) . Because integrin signaling is involved in the Akt pathway (32), we examined whether integrin was required to mediate SP-induced antiapoptotic effects. Western blot analyses showed that SP induced integrin ␣V␤3 phosphorylation in a timeand dose-dependent manner (see SI Fig. 9 ). Addition of a ␣V␤3 neutralizing antibody, but not a control antibody, blocked SPinduced phospho-Jak2 and phospho-Akt signaling (Fig. 5A) . These results indicate that SP-induced integrin ␣V␤3 phosphorylation appears to be upstream of Jak2 and Akt phosphorylation in response to SP.
We next examined whether neutralization of the two integrin isoforms ␣V␤3 and ␣V␤5 affects PARP cleavage in response to SP. In the absence of SP, none of the neutralizing antibodies affected the amount of PARP cleavage. However, only integrin ␣V␤3, but not integrin ␣V␤5, blockade disrupted the antiapoptotic effects of SP on cleaved PARP expression in the presence of tamoxifen (Fig.  5B) . Thus, integrin ␣V␤3 specifically mediates SP-induced antiapoptotic effects in colonocytes.
In Vivo Experiments. Effects of NK-1R and Akt antagonists in the recovery
phase of DSS-induced colitis. The in vivo importance of SP-mediated Akt signaling was studied in the DSS model of colitis in mice. Five days of DSS exposure resulted in substantial inflammatory changes in mouse colon, evidenced by increased colitis score (Fig. 6A) ; after removal of DSS for an additional 5 days, mice had lower colitis score and mild loss of body weight (Fig. 6A) , indicating recovery from colitis. However, mice treated with the NK-1R antagonist during the recovery phase had increased colitis clinical score (Fig. 6A) and further reduced body weight (Fig. 6B) . Administration of the Akt inhibitor V to mice for 10 days also worsened colonic inflammation to an extent similar to animals receiving NK-1R antagonist (Fig. 6) . Administration of the Akt antagonist together with the NK-1R antagonist did not worsen these parameters of inflammation compared with administration of the antagonists individually (Fig. 6) , indicating that the effects of these two inhibitors are likely mediated by similar pathways. Colitis-associated apoptosis is exacerbated by a NK-1R antagonist. Next, Western blot analysis was used to examine the expression of apoptotic markers during DSS-induced colitis. Colonic expression of the proapoptotic cleaved caspase 3 was very low 1 day after DSS exposure and highly expressed between days 3 and 8 (Fig. 7A) . Expression of cleaved caspase 3, however, was diminished at day 10 of the experiment (late recovery stage) (Fig. 7A) . Expression of phospho-Akt was very low between days 1 and 3 of DSS exposure (early stage of colitis), increased at day 5, and then reduced to a lower level at day 10 of the experiment (Fig. 7A) . The total (phosphorylated and nonphosphorylated) Akt1 isoform protein, however, remained constant (Fig. 7A) , whereas the Akt2 and Akt3 isoforms were undetectable (data not shown). As shown in Fig. 7B , administration of CJ-12,255 during the recovery phase of colitis augmented cleaved caspase 3 expression, whereas the Akt inhibitor V, with or without CJ-12,255, resulted in enhanced apoptosis associated with strong cleaved caspase 3 expression. However, the low level of Akt phosphorylation was further reduced after administration of CJ-12,255 and/or Akt inhibitor V (Fig. 7B) . These results were confirmed by TUNEL assays. Apoptotic cells were evident in the colon of mice at day 10 of the experiment in the DSS group (Fig.  7C) . However, administration of CJ-12,255 or Akt V increased the number of apoptotic cells (Fig. 7C) , confirming the Western blot results shown in Fig. 7B . Thus, NK-1R blockade during recovery from colitis enhances colonic apoptotic signaling.
Discussion
Our prior evidence with NK-1R-deficient mice indicated that SP by binding to NK-1R plays a dual role in the development and maintenance of colonic inflammation. NK-1R-deficient mice are protected during the acute phase of colitis, but they have an enhanced inflammatory response at a later stage chronic colitis (15) . Improved mucosal healing in the chronic phase of colitis in NK-1R-deficient mice was shown to involve metalloproteinasedependent EGFR transactivation, leading to cell proliferation in colonic fibroblasts and human colonocytes (9, 14, 15) . In this study we report that in colonocytes, SP, by NK-1R activation, stimulates phosphorylation of the antiapoptotic molecule Akt and reduces colonocyte cell death and apoptosis both in vitro and in vivo. These results indicate that SP-mediated Akt phosphorylation may play an important role in mucosal healing during recovery from colitis. As well, our findings further associate SP with the pathophysiology of IBD because increased apoptosis and oxidative stress are evident in the colon of patients with ulcerative colitis and Crohn's disease (33) (34) (35) .
Under normal conditions, NK-1R expression in colonocytes is low (36) , but its expression is increased in colonocytes in IBD patients (36, 37) and ileal epithelial cells during C. difficile toxin A-induced experimental enteritis (38) . Previous studies also indicated expression of NK-1R in intestinal epithelial cells (4, 5) . We also found low levels of NK-1R in nontransfected NCM460 (data not shown) that do not respond to SP stimulation by increased Akt phosphorylation compared with NK-1R-transfected cells (SI Fig.  10 ). However, SP induces a small time-dependent Akt phosphorylation in U373MG astrocytoma cells expressing endogenous NK-1R (SI Fig. 11 A and B) .
We show here that SP activates the antiapoptotic Akt pathway that prevents further tissue damage during colitis and rescues colonic epithelial cells from apoptosis. Treatment with the Akt inhibitor V resulted in colonic apoptosis (Fig. 7B) , indicating that Akt-related antiapoptotic signaling is important for preservation of colon tissue integrity. We also present evidence that Jak2 upstream of Akt is involved in this SP response. Interestingly, Jak2 was recently shown to also mediate cyclooxygenase 2 (COX-2) gene up-regulation and prostaglandin E 2 release in human colonocytes exposed to SP (27) and evidence was presented indicating that COX-2 promotes intestinal inflammatory responses (39) . Thus, SP-induced Jak2 phosphorylation may mediate both proinflammatory and antiapoptotic signaling pathways. However, the mechanism(s) by which these two diverse pathways operate during intestinal inflammation remains to be investigated.
Previous results by DeFea and colleagues (26) demonstrated that in kidney epithelial cells SP, by means of NK-1R, stimulates cell proliferation and inhibits apoptosis by a mechanism involving the formation of a ␤-arrestin-dependent scaffolding complex that includes internalized NK-1R, src, and the MAPK ERK1/2. We have not examined whether SP-induced Akt phosphorylation and inhibition of apoptosis involves the formation of a ␤-arrestin scaffolding complex in colonic epithelial cells. However, an Akt/␤-arrestin/ protein phosphatase 2A signaling complex is also involved in dopaminergic neurotransmission (40) . Moreover, prostaglandin E 2 induces the association of a prostaglandin E receptor 4/␤-arrestin 1/c-Src signaling complex, resulting in the transactivation of the EGFR and downstream Akt signaling (41) . SP binding to NK-1R causes transactivation of the EGFR and MAPK phosphorylation linked to cell proliferation (9, 14) and protection from colitis (15) . Several groups also showed an EGFR-Akt-MAPK cross-talk in several cell types (42, 43) . Preliminary experiments in our laboratory indicate that blocking activated EGFR partially inhibits SPinduced Akt phosphorylation (data not shown), indicating a possible communication between SP-associated EGFR and Akt pathways in proliferation and survival of colonic epithelial cells.
Integrins are cell-surface receptors involved in several important cell functions, including adhesion to the extracellular matrix, cell proliferation, and wound repair (32) . Our results indicate that integrin ␣V␤3, but not ␣V␤5, mediates SP-associated antiapoptotic responses induced by tamoxifen. We also found that integrin ␣V␤3 (vitronectin receptor) mediates SP-induced Jak2 and Akt phosphorylation. Consistent with our findings, Wang et al. (44) recently showed that P2Y(2)R-mediated astrocyte migration and Akt activation are also inhibited by anti-␣(V) integrin antibody. Our findings of the involvement of integrin in SP-induced Jak2 activation is supported by another study, which showed that interaction of endothelial cell integrin with matrix proteins induces transient tyrosine phosphorylation of Jak2 and STAT5A (45) . In addition, ␣V␤3 integrin has been associated with Akt phosphorylation and signaling (46) . Clinical relevance of integrins in the pathophysiology of IBD has been demonstrated because an integrin ␣4 neutralizing antibody, natalizumab, has been recently used for treating Crohn's disease (47) , whereas the more specific anti-␣4␤7 integrin monoclonal antibody MLN-02 is considered as a therapeutic approach for ulcerative colitis (48) .
In summary, the evidence reported here demonstrating that SP by binding to NK-1R phosphorylates and activates Akt has important implications for a healing role of SP and NK-1R blockade in the pathophysiology of colitis and may help us devise therapeutic strategies against intestinal inflammation, including IBD.
Materials and Methods
Cell Cultures of Human Colonocytes. Human nontransformed colonic epithelial NCM460 colonocytes (Incell, San Antonio, TX) were stably transfected with NK-1R (NCM460-NK-1R) as described (9, 49) . Cells were cultured in M3D medium containing 10% FCS (Invitrogen, Carlsbad, CA), and 1% penicillin/streptomycin (Invitrogen). Human U373MG astrocytoma cells (American Type Culture Collection, Manassas, VA) expressing endogenous NK-1R were cultured in minimum essential medium containing 10% FCS (Invitrogen), 25 mM sodium bicarbonate (Sigma, St. Louis, MO) and 10 mM sodium pyruvate (Sigma). Absorbance at 490 nm (indicating cell viability) was measured by using a 96-well plate reader as described in ref. 9 to quantify cell proliferation in these cells.
In Situ Detection of Apoptosis in Cultured Colonocytes. NCM460-NK-1R colonocytes, seeded on chamber slides (no. 3544104; BD Falcon, Bedford, MA) at 50% confluence, were pretreated with Akt inhibitor V (40 M) for 30 min and then exposed to tamoxifen (10 M) in the presence or absence of SP (10 nM) for 8 h at 37°C. Cells were then fixed in 4% paraformaldehyde for 25 min and permeabilized with a 0.2% Triton X-100 solution in PBS for 5 min. Slides were processed for TUNEL assay (Promega) as described.
Western Blot Analyses. SP-treated cells were lysed in 1ϫ lysis buffer (62.5 mM Tris⅐HCl/2% SDS/10% glycerol/0.01% bromophenol blue/1% 2-mercaptoethanol). Equal amounts of cell extracts were fractionated by SDS/10-12.5% PAGE, and proteins were transferred onto nitrocellulose membranes (Bio-Rad Laboratories, Hercules, CA) at 400 mA for 2 h at 4°C. Membranes were blocked in 5% nonfat milk in 50 mM Tris (pH 7.5)/0.15 M NaCl/0.05% Tween 20 (TBST) and then incubated with antibodies against cleaved caspase 3, caspase 3, cleaved PARP, PARP, phospho-Akt (Ser-473), phospho-Jak2, ␤-actin (Cell Signaling Technology, Danvers, MA), Akt1, Akt2, Akt3 (Upstate Biotechnology, Lake Placid, NY), and phospho-integrin ␤3(Y759) (Santa Cruz Biotechnology, Santa Cruz, CA). In some experiments, Western blot bands were quantified by densitometry by using Scion (Frederick, MD) image analysis software with normalization of the phosphorylated protein to the corresponding band of control (␤-actin) signal from the same samples.
Induction of Colitis by DSS and Pharmacological Inhibition of NK-1R
and Akt. Male 8-to 10-week-old C57BL/6 mice (n ϭ 6 per group) were purchased from Charles River Laboratories (Wilmington, MA) and maintained at the animal research facility of Beth Israel Deaconess Medical Center under standard environmental conditions. Mice received standard pelleted chow and tap water ad libitum, except the colitis group, which received water containing DSS 5% (wt/vol) as described (15) . After 5 days, DSS was withdrawn and mice were switched to drinking water for another 5 days. In some experiments, mice (n ϭ 6 per group) were injected i.p. with 200 l of PBS containing the specific NK-1R antagonist CJ-12,255 (2.5 mg/kg twice a day), or PBS alone (during days 6-10). To determine the role of Akt, another group of mice (treated with either vehicle or vehicle containing CJ-12,255, n ϭ 6) was injected daily with Akt inhibitor V (2 mg/kg once per day i.p.). At the end of the experiments, mice were killed by carbon dioxide, full thickness colon tissues were dissected and homogenized in RIPA buffer (Santa Cruz), and equal amounts of proteins (40 g per lane) were loaded for Western blot experiments. Some colon tissues were fixed in formalin and embedded in paraffin for TUNEL assays.
Measurement of Colitis Severity (Clinical Score for DSS Colitis). The severity of colitis was estimated by measuring body weight loss, stool consistency, and presence of fecal blood, leading to a clinical colitis score (scale 0-4) as described in ref. 15 .
In Situ Detection of Apoptosis by Colorimetric TUNEL Assay. Deparaffinized slides were fixed in 4% paraformaldehyde and treated with proteinase K to permeablize the tissues. The slides were incubated with a labeling reaction mix for 1 h at 37°C according to manufacturer's instructions (50) (DeadEnd Colorimetic TUNEL System no. G7130; Promega). The reaction was stopped by addition of 2ϫ SSC, slides were incubated with streptavidin-horseradish peroxidase (1:500 dilution in PBS), and apoptosis was localized with enhanced diaminobenzidine solution included in this TUNEL assay kit.
Statistical Analysis. Results were analyzed by using the Prism professional statistics software program (Graphpad Software, San Diego, CA). Analyses of variances were used for intergroup comparisons.
